Shimizu K - Search Results

1

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.

Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC. Moriuchi S, et al. Among authors: shimizu k. Gene Ther. 2000 Sep;7(17):1483-90. doi: 10.1038/sj.gt.3301265. Gene Ther. 2000. PMID: 11001368

2

Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.

Tamura K, Tamura M, Ikenaka K, Yoshimatsu T, Miyao Y, Nanmoku K, Shimizu K. Tamura K, et al. Among authors: shimizu k. Gene Ther. 2001 Feb;8(3):215-22. doi: 10.1038/sj.gt.3301371. Gene Ther. 2001. PMID: 11313793

3

Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells.

Tamura M, Shimizu K, Yamada M, Miyao Y, Hayakawa T, Ikenaka K. Tamura M, et al. Among authors: shimizu k. Hum Gene Ther. 1997 Mar 1;8(4):381-91. doi: 10.1089/hum.1997.8.4-381. Hum Gene Ther. 1997. PMID: 9054513

4

Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumors.

Tamura M, Ikenaka K, Tamura K, Yoshimatsu T, Miyao Y, Kishima H, Mabuchi E, Shimizu K. Tamura M, et al. Among authors: shimizu k. Gene Ther. 1998 Dec;5(12):1698-704. doi: 10.1038/sj.gt.3300781. Gene Ther. 1998. PMID: 10023449

5

Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma.

Mabuchi E, Shimizu K, Miyao Y, Kaneda Y, Kishima H, Tamura M, Ikenaka K, Hayakawa T. Mabuchi E, et al. Among authors: shimizu k. Gene Ther. 1997 Aug;4(8):768-72. doi: 10.1038/sj.gt.3300478. Gene Ther. 1997. PMID: 9338004

6

Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.

Ikenaka K, Sasaki M, Tamura K, Tamura M, Miyao Y, Nanmoku K, Kawano Y, Nakahira K, Yoshimine T, Shimizu K. Ikenaka K, et al. Among authors: shimizu k. Hum Cell. 2001 Mar;14(1):49-58. Hum Cell. 2001. PMID: 11436353

7

Structural characterization and chromosomal localization of the MAGE-E1 gene.

Kawano Y, Sasaki M, Nakahira K, Yoshimine T, Shimizu K, Wada H, Ikenaka K. Kawano Y, et al. Among authors: shimizu k. Gene. 2001 Oct 17;277(1-2):129-37. doi: 10.1016/s0378-1119(01)00698-9. Gene. 2001. PMID: 11602350

8

Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.

Miyao Y, Shimizu K, Moriuchi S, Yamada M, Nakahira K, Nakajima K, Nakao J, Kuriyama S, Tsujii T, Mikoshiba K, et al. Miyao Y, et al. Among authors: shimizu k. J Neurosci Res. 1993 Nov 1;36(4):472-9. doi: 10.1002/jnr.490360413. J Neurosci Res. 1993. PMID: 7505843

9

Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.

Miyao Y, Shimizu K, Tamura M, Akita H, Ikeda K, Mabuchi E, Kishima H, Hayakawa T, Ikenaka K. Miyao Y, et al. Among authors: shimizu k. Jpn J Cancer Res. 1997 Jul;88(7):678-86. doi: 10.1111/j.1349-7006.1997.tb00436.x. Jpn J Cancer Res. 1997. PMID: 9310141 Free PMC article.

10

FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum.

Miyao Y, Ikenaka K, Kishima H, Tamura M, Nakamura K, Kurumi M, Hayakawa T, Shimizu K. Miyao Y, et al. Among authors: shimizu k. Hum Gene Ther. 1997 Sep 1;8(13):1575-83. doi: 10.1089/hum.1997.8.13-1575. Hum Gene Ther. 1997. PMID: 9322090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,335 results

Search Page

Filters